Osaic Holdings
RLMD icon

Osaic Holdings’s Relmada Therapeutics RLMD Stock Holding History

Osaic Holdings’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34 Hold
5
– – ﹤0.01% 7694
2025
Q4 		$24 Hold
5
– – ﹤0.01% 7730
2025
Q3 		$9 Hold
5
– – ﹤0.01% 7862
2025
Q2 		$3 Hold
5
– – ﹤0.01% 7717
2025
Q1 		$1 Sell
5
-27
-84% -$9 ﹤0.01% 7417
2024
Q4 		$16 Buy
32
+5
+19% +$12 ﹤0.01% 7334
2024
Q3 		$87 Hold
27
– – ﹤0.01% 7255
2024
Q2 		$81 Hold
27
– – ﹤0.01% 7266
2024
Q1 		$126 Hold
27
– – ﹤0.01% 7018
2023
Q4 		$112 Hold
27
– – ﹤0.01% 7103
2023
Q3 		$81 Hold
27
– – ﹤0.01% 7242
2023
Q2 		$66 Sell
27
-29
-52% -$80 ﹤0.01% 7318
2023
Q1 		$127 Sell
56
-721
-93% -$2.49K ﹤0.01% 7313
2022
Q4 		$3K Sell
777
-4,850
-86% -$42.6K ﹤0.01% 6535
2022
Q3 		$208K Buy
5,627
+850
+18% +$23.5K ﹤0.01% 3698
2022
Q2 		$91K Buy
4,777
+1,875
+65% +$40.9K ﹤0.01% 4499
2022
Q1 		$79K Buy
2,902
+2,800
+2,745% +$57.9K ﹤0.01% 4767
2021
Q4 		$3K Sell
102
-707
-87% -$15.7K ﹤0.01% 6900
2021
Q3 		$21K Buy
809
+286
+55% +$7.66K ﹤0.01% 5740
2021
Q2 		$17K Buy
523
+198
+61% +$6.88K ﹤0.01% 5759
2021
Q1 		$12K Hold
325
– – ﹤0.01% 5789
2020
Q4 		$10K Hold
325
– – ﹤0.01% 5522
2020
Q3 		$12K Buy
325
+250
+333% +$9.66K ﹤0.01% 5186
2020
Q2 		$3K Hold
75
– – ﹤0.01% 5688
2020
Q1 		$3K Buy
+75
New +$3.02K ﹤0.01% 5566

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Osaic Holdings's RLMD Position: Q1 2026 in Review

Osaic Holdings held its Relmada Therapeutics (RLMD) position steady in Q1 2026 at 5 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #7694.

Osaic Holdings first reported a position in RLMD in Q1 2020 and has held it in 25 quarters since. The position peaked at $208K in Q3 2022. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Osaic Holdings held 5 shares of Relmada Therapeutics worth $34 as of Q1 2026.
  • Osaic Holdings left its Relmada Therapeutics share count unchanged in Q1 2026.
  • Relmada Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7694 holding.
  • Osaic Holdings first reported a position in Relmada Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Relmada Therapeutics position peaked at $208K in Q3 2022.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.